Joanna Popiolek-Kalisz/LinkedIn
Oct 17, 2026, 02:31
Joanna Popiolek-Kalisz: Talking about Novel Pharmacotherapy for Hypertension at CV Prevention and Intervention
Joanna Popiolek-Kalisz, Associate Professor and Head of the Department of Clinical Dietetics at Medical University of Lublin, Consulant in Cardiology at Grupa CenterMed and Magnoliowa Non-Public Healthcare Facility, shared a post on LinkedIn:
“CV Prevention and Intervention was a great fusion of two areas of cardiology that do not often mix!
It was of course also an opportunity to meet my great friends and colleagues who made this event so exceptional.
Thank you for the invitation to talk about novel pharmacotherapy of hypertension as the team.”
Stay updated with Hemostasis Today.
-
Oct 17, 2026, 03:56Ghaith Abu-Zeinah: ASH Publishes 2026 Guidelines for Myelofibrosis Management in Blood Advances
-
Oct 17, 2026, 03:48Tristan Siokos: Why Vascular Occlusion Is More Than Just Clots – Breakdown of the 8 Pathways
-
Oct 17, 2026, 02:36Archil Jaliashvili: Oxygen Transport in Capillaries
-
Oct 17, 2026, 02:35Carly Newton: Understanding Access to Red Blood Cell Exchange for People Living With SCD
-
Oct 17, 2026, 02:34Raising Awareness of Blood Clots During and After Pregnancy – Thrombosis UK
-
Oct 17, 2026, 02:33Alaa Salamat: Our Research Accepted for Publication at ASH 2026
-
Oct 17, 2026, 02:32Mohammed Al Sharif: Discussing Factor XIII Testing and Its Clinical Significance
-
Oct 17, 2026, 02:00How Antiphospholipid Syndrome Can Affect the Adrenal Glands – APS Foundation of America
-
Oct 17, 2026, 01:59Liza-Marie Johnson: How Far Should Clinicians Go to Influence Parents’ Decisions?